Core One Labs Inc. (CLABF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Oct 23, 2026
Core One Labs Market Cap
Core One Labs has a market cap or net worth of $47 as of October 30, 2026. It is the 53,088th most valuable company in the world and the 9,057th biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
47.00
Enterprise Value
n/a
Revenue
338.91K
Global Rank
Country Rank
#9,057 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 25, 2015, Core One Labs's market cap has decreased from 3.89M to 47.00, a decrease of -100.00%. That is a compound annual growth rate of -63.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 47.00 | -90.02% |
| Dec 17, 2025 | 471.00 | -99.99% |
| Dec 31, 2024 | 4.24M | -62.03% |
| Dec 29, 2023 | 11.16M | -39.24% |
| Dec 30, 2022 | 18.37M | 57.77% |
| Dec 31, 2021 | 11.65M | -76.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 0913693 B.C. | 74.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Better Therapeutics | 55.00 |
| Panacos Pharmaceuticals | 54.00 |
| Iterum Therapeutics | 53.00 |
| Baudax Bio | 52.00 |